Use of recombinant albumin in dialysis after liver failure

Details Use of recombinant albumin in dialysis after liver failure Use of recombinant albumin in dialysis after liver failure

B - Operations, Transporting

01

D

B01D 61/00 (2006.01) A61K 38/38 (2006.01) A61M 1/14 (2006.01) A61M 1/16 (2006.01) B01D 15/00 (2006.01) B01D 61/24 (2006.01) B01D 67/00 (2006.01) B01D 69/02 (2006.01) B01D 69/14 (2006.01) C07K 14/76 (2006.01) C07K 14/765 (2006.01)

Patent

CA 2514981

The present invention relates to the use of recombinant HSA in dialysis, wherein the recombinant HSA has been purified from accompanying fatty acids during its production.

Cette invention a trait à l'utilisation d'albumine sérique humaine (HSA) de recombinaison aux fins d'une dialyse. Lors de sa production, on a retiré de cette HSA de recombinaison tous les acides gras qu'elle contenait.

Affiliated with

Also associated with

Rating

Use of recombinant albumin in dialysis after liver failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of recombinant albumin in dialysis after liver failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of recombinant albumin in dialysis after liver failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2054289